Bal Pharma

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE083D01012
  • NSEID: BALPHARMA
  • BSEID: 524824
INR
91.00
1.62 (1.81%)
BSENSE

Aug 10

BSE+NSE Vol: 39.65 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 555664,
    "name": "Bal Pharma",
    "stock_name": "Bal Pharma",
    "full_name": "Bal Pharma Ltd",
    "name_url": "stocks-analysis/bal-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "91.00",
    "chg": 1.62,
    "chgp": "1.81%",
    "dir": 1,
    "prev_price": "89.38",
    "mcapval": "142.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524824,
    "symbol": "BALPHARMA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE083D01012",
    "curr_date": "Aug 10",
    "curr_time": "",
    "bse_nse_vol": "39.65 k",
    "exc_status": "Active",
    "traded_date": "Aug 10, 2026",
    "traded_date_str": "2026 08 10",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/bal-pharma-555664-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Bal Pharma Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bal-pharma-ltd-is-rated-strong-sell-4002686",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BalPharmaLtd_mojoScore_4002686.png",
        "date": "2026-05-21 10:10:58",
        "description": "Bal Pharma Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 28 May 2025, reflecting a shift from the previous 'Sell' grade. However, the analysis and financial metrics discussed below are based on the stock's current position as of 21 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "When is the next results date for Bal Pharma Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-bal-pharma-ltd-3999679",
        "imagepath": "",
        "date": "2026-05-19 23:17:37",
        "description": "The next results date for Bal Pharma Ltd is scheduled for 27 May 2026...."
      }
    ],
    "total": 15,
    "sid": "555664",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/bal-pharma-555664"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Considering Inter-Alia The Unaudited (Standalone And Consolidated) Financial Statements Of The Company For The First Quarter Ended 30Th June 2026 And Other General Business Matters",
      "datetime": "05-Aug-2026",
      "details": "Bal Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve Pursuant to Regulation 29 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that a meeting of the Board of Directors of Bal Pharma Limited is scheduled to be held on Wednesday August 12 2026 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30 2026 (Q1/2026-27) and such other matters as may be considered necessary with the permission of the Chair.",
      "source": "BSE"
    },
    {
      "caption": "Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 : Intimation Regarding Notice Of Postal Ballot",
      "datetime": "30-Jul-2026",
      "details": "Company Providing opportunity to shareholders to Submit their Comments on Corrigendum to the Postal ballot notice",
      "source": "BSE"
    },
    {
      "caption": "Intimation Regarding Corrigendum To The Postal Ballot Notice",
      "datetime": "23-Jul-2026",
      "details": "In Continuation of Postal Ballot Notice dated 09th July 2026 Submitting Corrigendum as integral part to the Said Notice.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "12 Aug 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Bal Pharma Ltd has declared <strong>12%</strong> dividend, ex-date: 18 Sep 25",
          "dt": "2025-09-18",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock-recommendationAnnouncement

Board Meeting Intimation for Considering Inter-Alia The Unaudited (Standalone And Consolidated) Financial Statements Of The Company For The First Quarter Ended 30Th June 2026 And Other General Business Matters

05-Aug-2026 | Source : BSE

Bal Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve Pursuant to Regulation 29 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that a meeting of the Board of Directors of Bal Pharma Limited is scheduled to be held on Wednesday August 12 2026 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30 2026 (Q1/2026-27) and such other matters as may be considered necessary with the permission of the Chair.

Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 : Intimation Regarding Notice Of Postal Ballot

30-Jul-2026 | Source : BSE

Company Providing opportunity to shareholders to Submit their Comments on Corrigendum to the Postal ballot notice

Intimation Regarding Corrigendum To The Postal Ballot Notice

23-Jul-2026 | Source : BSE

In Continuation of Postal Ballot Notice dated 09th July 2026 Submitting Corrigendum as integral part to the Said Notice.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

12 Aug 2026

stock-summary
DIVIDEND

Bal Pharma Ltd has declared 12% dividend, ex-date: 18 Sep 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available